Cardiovascular
Avidity and BMS enter $2.3bn deal for cardiovascular targets
Avidity Biosciences has entered an international licencing and research partnership with Bristol Myers Squibb (BMS) to discover, develop and market cardiovascular targets…
Expanded use of oral blood thinners by NHS has saved “thousands of lives”
England’s National Health Service (NHS) has hailed the impact of direct oral anticoagulants (DOACs), citing that thousands of lives have…
International initiative launched to create personalised cardiovascular care
International public-private research consortium iCARE4CVD (individualised care from the early risk of cardiovascular disease to established heart failure) has launched…
Tourmaline shifts focus to developing anti-IL6 antibody following merger
Tourmaline Bio has completed the merger with Talaris Therapeutics and will begin trading on the Nasdaq global market as Tourmaline…
Novo Nordisk to acquire hypertension therapy ocedurenone
Novo Nordisk has signed an agreement to acquire ocedurenone to treat uncontrolled hypertension from KBP Biosciences for $1.3bn. Uncontrolled hypertension…
Novo Nordisk and Evotec launch translational drug discovery accelerator
Novo Nordisk has entered a partnership with Evotec to kickstart a drug discovery accelerator called LAB eN² that will combine the…
Novo Nordisk and Valo to develop cardiometabolic disease therapies
Novo Nordisk has signed an agreement with Valo Health for the discovery and development of new therapies to treat cardiometabolic diseases. The…
Boehringer and Lilly gain FDA approval for kidney disease therapy
Boehringer Ingelheim and Eli Lilly and Company have received approval from the US Food and Drug Administration (FDA) for Jardiance…
Hasten and LIB Therapeutics enter $325m CVD drug development deal
Hasten Biopharmaceutical has signed an agreement to acquire the rights for the development and commercialisation of LIB Therapeutics’ cardiovascular disease (CVD) drug…
Novo Nordisk and Broad Institute to explore drug targets for diabetes, CMDs
Novo Nordisk has entered a research collaboration with the Broad Institute of Massachusetts Institute of Technology and Harvard to detect…
